An innovative approach to capacity management.
Apr 1, 2013
By:
Jim Miller
An innovative approach to capacity management.
|
Is the contract-only CMO an endangered species?
Feb 1, 2013
By:
Jim Miller
Is the contract-only CMO an endangered species?
|
Measuring the size of the market for contract manufacturing services requires a careful hand.
Oct 1, 2012
By:
Jim Miller
Measuring the size of the market for contract manufacturing services requires a careful hand.
|
The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
Sep 1, 2012
By:
Jim Miller
The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
|
Service providers must focus on delivering a superior customer experience.
May 1, 2012
By:
Jim Miller
Service providers must focus on delivering a superior customer experience.
|
The evolving bio/pharmaceutical business model poses risk for CMOs.
Mar 1, 2012
By:
Jim Miller
The evolving bio/pharmaceutical business model poses risk for CMOs.
|
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
Jan 1, 2012
By:
Jim Miller
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
|
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Dec 1, 2011
By:
Jim Miller
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
|
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Oct 1, 2011
By:
Jim Miller
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
|
|
